Explore PMOS Research
Search 20,710 PMOS papers published between 2015 and 2025. Filter by research topic, country, year range, or co-investigated condition to find where the field is active and where the gaps are.
Total citations
289,983
Peak year
2025(3,021 articles)
Avg citations / article
14
Publications per year
Topics
All research areas ⓘArticle mentionsA paper tagged with multiple topics counts once in each. The Overview uses fractional counting instead. See methodology.
Countries
All countries
Top journals
All filters
Top institutions
All filters
Where in the world is each topic being researched?
Toggle between Revealed Comparative Advantage (RCA), a specialisation index where values above 1.0 mean a country focuses on that topic more than average, and raw article counts.
| Hormones | Metabolic | Fertility | Epidemiol. | Pharma | Diagnos. | Genetics | Mental | Nutrition | Molecular | Inflamm. | Cell Bio | Lifestyle | Microbiome | Dermatol. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| China | 1.0 | 0.9 | 1.1 | 0.9 | 1.1 | 0.7 | 1.5 | 0.4 | 0.7 | 1.9 | 1.1 | 2.1 | 0.5 | 1.4 | 0.2 |
| United States | 1.0 | 1.1 | 1.0 | 1.3 | 0.8 | 1.1 | 0.9 | 1.4 | 0.6 | 0.6 | 0.7 | 0.6 | 1.0 | 0.6 | 1.3 |
| India | 0.9 | 0.9 | 0.9 | 0.9 | 0.9 | 1.9 | 1.1 | 1.1 | 1.7 | 0.8 | 0.7 | 0.6 | 1.2 | 1.2 | 1.9 |
| Iran | 1.0 | 0.9 | 0.9 | 0.9 | 1.6 | 0.5 | 0.7 | 1.2 | 1.8 | 0.9 | 2.0 | 0.7 | 1.1 | 0.9 | 0.8 |
| Turkey | 1.2 | 1.2 | 0.8 | 0.4 | 0.4 | 1.4 | 0.5 | 1.0 | 1.0 | 0.6 | 1.7 | 0.5 | 0.4 | 1.3 | 1.4 |
| United Kingdom | 0.9 | 1.0 | 0.9 | 1.3 | 1.0 | 0.9 | 0.8 | 2.0 | 0.9 | 0.5 | 0.7 | 0.3 | 1.8 | 0.5 | 1.3 |
| Australia | 0.8 | 1.1 | 0.9 | 1.9 | 1.1 | 0.8 | 0.6 | 2.1 | 0.7 | 0.2 | 0.1 | 0.5 | 4.0 | 0.4 | 0.5 |
| Italy | 1.1 | 1.2 | 1.0 | 0.8 | 0.9 | 1.2 | 0.5 | 0.8 | 1.5 | 0.6 | 0.7 | 0.3 | 0.5 | 1.0 | 1.0 |
| Egypt | 1.0 | 0.8 | 1.9 | 0.4 | 1.7 | 0.8 | 0.4 | 0.6 | 1.1 | 0.6 | 1.0 | 0.5 | 0.3 | 0.3 | 2.2 |
| Poland | 1.3 | 1.4 | 0.5 | 0.6 | 0.4 | 0.8 | 0.6 | 1.2 | 0.8 | 0.6 | 1.2 | 0.4 | 1.1 | 1.7 | 1.6 |
Studies8,421–8,440 of 20,710
All studies
CTLA4+rs231775 gene polymorphism increases PCOS, regardless of the levels of interleukin-6 and tumor necrosis factor-α in the serum
THU626 Impact Of Body Mass Index On Clinical And Endocrinological Characteristics Of Indian PCOS Population
Developmental origins and genetic basis of polycystic ovary syndrome
An Intricate relationship between Microbes and Metabolites leads of Novel PCOS Biomarkers
Selenium supplements and Polycystic Ovary syndrome and its key risk factors: a Mendelian Randomization Study
Acetate supplementation improves adipose-hepatic gluco-lipid dysregulation in experimental PCOS model by repression of NF- κB/NLRP3 immunoreactivity
ENDOMETRIAL FACTORS AS A CAUSE OF INFERTILITY AND IMPLANTATION FAILURES IN POLYCYSTIC OVARY SYNDROME
Comorbidities in women with polycystic ovary syndrome: a sibling study
SAT375 Impact of Flutamide on Wake vs. Sleep LH Pulse Frequency in PCOS: An Interim Analysis
Investigation the role of vaspin and some hormones in pathogenicity of polycystic ovary syndrome in Diyala Province
Role of luteinizing and follicle-stimulating hormones in women diagnosed with polycystic ovary syndrome
Author response for "Regulatory emotional self‐efficacy and self‐compassion mediate anxiety, depression, body image distress and subjective well‐being in women with polycystic ovary syndrome: A cross‐sectional study"
Supplementary Material for: Identifying genetic factors of polycystic ovary syndrome in women with epilepsy: a whole-genome sequencing study
A REVIEW AND CURRENT SITUATION OF PCOS WITH INFERTILITY
Insulin resistance, a metabolic disorder in women with polycystic ovary syndrome and its implications for clinical management
Ovarian mitochondrial dysfunction in letrozole-induced PCOS rat model: Therapeutic role of HDAC2 inhibition
Advances of the Regulation of Sex-Hormone Globulin in Polycystic Ovary Syndrome
Decision letter for "Cardiometabolic effects of SGLT2 inhibitors on polycystic ovary syndrome"
Influence of ovulation, anovulation and progestin on Phoenixin-20 and Nesfatin-1 in patients with polycystic ovary syndrome (PCOS)
SAT388 Does Obesity Drive the Development of Polycystic Ovary Syndrome (PCOS)? An Epidemiologic Study